Related Experiment Videos

Anti-thymocyte globulin overdosage--risk or potential benefit?

G J Zlabinger, E Pohanka, W Doleschel

The American Journal of Medicine

|February 1, 1988

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0).

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring.

ESMO open·2021

Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Regorafenib therapy in metastatic colorectal cancer patients: markers and outcome in an actual clinical setting.

Neoplasma·2018

Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.

Journal of thrombosis and haemostasis : JTH·2018

Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model.

Allergy·2017

See all related articles